269 related articles for article (PubMed ID: 35546702)
1. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
Afzal S; Nasir M
J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
[TBL] [Abstract][Full Text] [Related]
2. Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.
Sasani E; Pakdel F; Khodavaisy S; Salehi M; Salami A; Sohrabi M; Aminishakiba P; Amirafzali I; Salami Khaneshan A
Mycopathologia; 2024 Jan; 189(1):10. PubMed ID: 38231407
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and mucormycosis superinfection: the perfect storm.
Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
[TBL] [Abstract][Full Text] [Related]
4. Maxillary mucormycosis and aspergillosis in post-COVID-19 patients in Mexico: A case series.
Urias-Barreras CM; Rodríguez-Archilla A; Canizalez-Roman A; Bastidas DA; León-Sicairos NM
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101615. PubMed ID: 37648209
[TBL] [Abstract][Full Text] [Related]
5. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
[TBL] [Abstract][Full Text] [Related]
6. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Singh AK; Singh R; Joshi SR; Misra A
Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
[TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated mucormycosis - "The Black fungus" with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario.
Menia R; Raychaudhuri S; Agarwal C; Taneja J
Indian J Pathol Microbiol; 2023; 66(4):823-828. PubMed ID: 38084540
[TBL] [Abstract][Full Text] [Related]
10. Invasive Mucormycosis and Aspergillosis Coinfection Associated with Post-COVID-19 Pneumonia in a Tertiary Care Hospital.
Paul M; Sasidharan J; Taneja J; Chatterjee K; Abbas SZ; Chowdhury V; Das A
Med Mycol J; 2022; 63(3):59-64. PubMed ID: 36047183
[TBL] [Abstract][Full Text] [Related]
11. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
12. Mucormycosis in COVID-19 patients.
Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
[TBL] [Abstract][Full Text] [Related]
13. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
14. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
16. Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature.
Ramphul K; Verma R; Kumar N; Ramphul Y; Mejias S; Lohana P
Acta Biomed; 2021 Sep; 92(4):e2021271. PubMed ID: 34487063
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
20. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
